Thynk Capital, LLC. Company
Thynk Capital possess a historical investment performance in the top 1% of venture capital. Focused on investments in early stage pharma and biotech companies focused on extending HealthSpan and major diseases of Aging including Alzheimer's, Dementia, Kidney Disease, Cancer, Cardiovascular, Diabetes, Frailty, and Rare Disease which affect over 25% of the population and growing at 10%/year.
Technology:
Geroscience
Headquarters:
Las Vegas, Nevada, United States
Founded Date:
2011-03-04
Number Of Exists:
1
Employee Number:
1-10
Industry:
Biotechnology, Health Care
Investor Type:
For Profit